Literature DB >> 16416291

Humoral response of chicken infected with the microsporidium Encephalitozoon hellem.

K Saková1, B Sak, O Ditrich, M Kvác.   

Abstract

Chicken (Gallus gallus) were used as the experimental model for study of immune response against the microsporidium Encephalitozoon hellem (Didier et al., J Inf Dis 163:617-621, 1991) infection in birds. Two-day-old chicken were infected perorally or intraperitoneally with a dose of 10(7) spores of E. hellem. The anti-E. hellem immunoglobulin (Ig)A, IgY, and IgM antibody responses in sera and dropping sample extracts were determined by enzyme-linked immunosorbent assay. Results have shown specific antibody production in sera and intestinal secretions of infected birds. Chicken inoculated perorally developed the lowest antibody response. Microsporidian spores were not identified in the smears from cloacal swab samples of individual chicken. Intestinal segment cultures of perorally infected chicken cultivated in vitro showed the highest production of specific IgY and IgA antibodies in jejunum segments. In the further course of infection, the colon produced the highest amount of IgA, and the ileum and colon produced the highest amount of IgY.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16416291     DOI: 10.1007/s00436-005-0089-4

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  19 in total

Review 1.  Natural antibodies and complement link innate and acquired immunity.

Authors:  A F Ochsenbein; R M Zinkernagel
Journal:  Immunol Today       Date:  2000-12

2.  Mechanisms of resistance to the intracellular protozoan Encephalitozoon cuniculi in mice.

Authors:  E C Schmidt; J A Shadduck
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

3.  Encephalitozoon hellem in budgerigars (Melopsittacus undulatus).

Authors:  S S Black; L A Steinohrt; D C Bertucci; L B Rogers; E S Didier
Journal:  Vet Pathol       Date:  1997-05       Impact factor: 2.221

4.  Microsporidial keratoconjunctivitis in a patient without human immunodeficiency virus infection.

Authors:  B E Silverstein; E T Cunningham; T P Margolis; V Cevallos; I G Wong
Journal:  Am J Ophthalmol       Date:  1997-09       Impact factor: 5.258

5.  An enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to Encephalitozoon cuniculi and its use in determination of infections in man.

Authors:  W S Hollister; E U Canning
Journal:  Parasitology       Date:  1987-04       Impact factor: 3.234

6.  Diagnosis of disseminated microsporidian Encephalitozoon hellem infection by PCR-Southern analysis and successful treatment with albendazole and fumagillin.

Authors:  E S Didier; L B Rogers; A D Brush; S Wong; V Traina-Dorge; D Bertucci
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

7.  Microsporidiosis in a young ostrich (Struthio camelus).

Authors:  M L Gray; M Puette; K S Latimer
Journal:  Avian Dis       Date:  1998 Oct-Dec       Impact factor: 1.577

8.  Experimental microsporidiosis in immunocompetent and immunodeficient mice and monkeys.

Authors:  E S Didier; P W Varner; P J Didier; A M Aldras; N J Millichamp; M Murphey-Corb; R Bohm; J A Shadduck
Journal:  Folia Parasitol (Praha)       Date:  1994       Impact factor: 2.122

9.  The course of infection of Encephalitozoon cuniculi in immunodeficient and immunocompetent mice.

Authors:  J Gannon
Journal:  Lab Anim       Date:  1980-07       Impact factor: 2.471

10.  Treatment of microsporidial keratoconjunctivitis with topical fumagillin.

Authors:  M C Diesenhouse; L A Wilson; G F Corrent; G S Visvesvara; H E Grossniklaus; R T Bryan
Journal:  Am J Ophthalmol       Date:  1993-03-15       Impact factor: 5.258

View more
  1 in total

1.  Phylogenetic characterization of a microsporidium (Nosema sp. MPr) isolated from the Pieris rapae.

Authors:  Darui Chen; Zhongyuan Shen; Feng Zhu; Rui Guan; Jiange Hou; Jiao Zhang; Xiaofang Xu; Xudong Tang; Li Xu
Journal:  Parasitol Res       Date:  2012-07       Impact factor: 2.289

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.